Metformin,Glimperide & Atorvastatin Combination

Get a Price/Quote

Metformin,Glimperide & Atorvastatin Combination Specification

Drug Type
Specific Drug

Ingredients
Exeed-AG-1: (Metformin 500 mg + Glimpride 1 mg + Atorvastatin 10 mg), Exeed-AG-2: (Metformin 500 mg + Glimpride 2 mg + Atorvastatin 10 mg)

Physical Form
Tablets

Function
Other

Recommended For
Treatment of Type 2 Diabetes Mellitus associated with dyslipidemia

Suitable For
Adults, Aged Person

Metformin,Glimperide & Atorvastatin Combination Trade Information

Payment Terms
Western Union, Paypal, Cash in Advance (CID), Cheque, Cash Advance (CA)

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
Blister Pack, 5*2*10

Main Export Market(s)
Australia, North America, Eastern Europe, Africa, Central America, Middle East, South America, Western Europe, Asia

Main Domestic Market
All India

Certifications
WHO-GMP

About Metformin,Glimperide & Atorvastatin Combination

Metformin, Glimperide & Atorvastatin Combination is a specialized medication formulated for the treatment of Type 2 Diabetes Mellitus associated with dyslipidemia. The tablets integrate three powerful active ingredients: Metformin, Glimpride, and Atorvastatin. Available in two strengths, Exeed-AG-1 (500 mg Metformin + 1 mg Glimpride + 10 mg Atorvastatin) and Exeed-AG-2 (500 mg Metformin + 2 mg Glimpride + 10 mg Atorvastatin), this combination targets better glucose control while addressing abnormal cholesterol levels. Designed for adults and aged individuals, the tablets come in convenient physical form and are classified as specific drugs. This medication is recommended for achieving dual benefits: enhanced glycemic management and improved lipid profile in patients affected by diabetes complications. Tailored for export and supply, its quality ensures compliance with therapeutic standards.